Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In re: Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation
Case Number:
1:09-md-02118
Court:
Nature of Suit:
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Chipman Brown
- Farnan LLP
- Fish & Richardson
- Husch Blackwell
- Marshall Dennehey
- Morris James
- Potter Anderson
- Richards Layton
- Wiley Rein
- Winston & Strawn
Companies
- Anchen Pharmaceuticals Inc.
- Aptalis Pharma LLC
- Cephalon Inc.
- Impax Laboratories, Inc.
- Mylan NV
- Par Pharmaceutical Cos. Inc.
Sectors & Industries:
-
March 15, 2012
Impax Can't Shake Injunction On Generic Amrix
A Delaware federal judge on Thursday nixed Impax Laboratories Inc.'s bid to amend an injunction barring it from marketing a generic version of Cephalon Inc.'s muscle relaxant Amrix, ruling that a prior settlement does not give Impax the right to sell its generic.
-
December 12, 2011
Impax's Generic Amrix Must Stay Banned: Cephalon, Mylan
Cephalon Inc. and Mylan Inc. fired back Friday at Impax Laboratories Inc.'s bid to have itself excluded from an injunction barring generic versions of Cephalon's muscle relaxant Amrix, saying Impax is seeking an improper "do-over" of the decision.
-
May 20, 2011
Cephalon Granted TRO In Amrix Patent MDL
The Delaware federal judge overseeing the multidistrict litigation over Cephalon Inc.'s Amrix drug granted a temporary restraining order Friday that would prevent Mylan Pharmaceuticals Inc. from launching generic versions of the muscle relaxant while Cephalon appeals a ruling invalidating its patents.
-
May 12, 2011
Cephalon's Amrix IP Invalid, Infringed: Judge
The Delaware federal judge overseeing multidistrict litigation over Cephalon Inc.'s Amrix drug ruled Tuesday that Mylan Pharmaceuticals Inc. and Barr Laboratories Inc. infringed two patents covering the muscle relaxant, but also said the patents-in-suit were invalid for being obvious.